• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

关于 SARS-CoV-2 基因组特征、药物和疫苗开发的最新进展;全面的生物信息学综述。

Latest updates on SARS-CoV-2 genomic characterization, drug, and vaccine development; a comprehensive bioinformatics review.

机构信息

Department of Microbiology and Immunology, Faculty of Pharmacy, Ain Shams University, Organization of African Unity St., 11566, Abbassia, Cairo, Egypt.

Department of Microbiology and Immunology, Faculty of Pharmacy, Ain Shams University, Organization of African Unity St., 11566, Abbassia, Cairo, Egypt.

出版信息

Microb Pathog. 2021 May;154:104809. doi: 10.1016/j.micpath.2021.104809. Epub 2021 Feb 27.

DOI:10.1016/j.micpath.2021.104809
PMID:33647446
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7910145/
Abstract

Amid the COVID-19 outbreak, several bioinformatic analyses have been conducted on SARS-CoV-2 virus genome. Numerous studies rushed to fill the gap about this novel virus. Comparison with other related sequences, structural predictions of the produced proteins, determination of variations in amino acid residues and depiction of possible drug and vaccine targets have been the focus of scientific research from the beginning of this year. In addition to discussing the viral taxonomy, clinical features, life cycle, and genome organization, this review will focus on the recent updates in genome and viral proteins characterization and potential therapeutic and vaccine candidates developed so far. Comparative studies with related genomes and proteins provide understanding for the viral molecular mechanisms and suggest targets for therapeutics and vaccinology trials to stop the escalation of this new virus. This pandemic, with its resulting social and economic afflictions, will definitely have significant marks on our lives in the following years.

摘要

在 COVID-19 疫情期间,针对 SARS-CoV-2 病毒基因组进行了多项生物信息学分析。许多研究都急于填补有关这种新型病毒的空白。从今年年初开始,研究的重点是与其他相关序列进行比较、预测产生的蛋白质的结构、确定氨基酸残基的变异以及描绘可能的药物和疫苗靶点。除了讨论病毒分类学、临床特征、生命周期和基因组组织外,本综述还将重点介绍基因组和病毒蛋白特征的最新进展,以及迄今为止开发的潜在治疗和疫苗候选物。与相关基因组和蛋白质的比较研究为病毒的分子机制提供了理解,并为治疗学和疫苗学试验提供了靶点,以阻止这种新病毒的蔓延。这场大流行及其带来的社会和经济影响,肯定会在未来几年给我们的生活留下深刻的印记。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3aa/7910145/757d492a22da/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3aa/7910145/cd2c58c741b3/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3aa/7910145/757d492a22da/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3aa/7910145/cd2c58c741b3/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3aa/7910145/757d492a22da/gr2_lrg.jpg

相似文献

1
Latest updates on SARS-CoV-2 genomic characterization, drug, and vaccine development; a comprehensive bioinformatics review.关于 SARS-CoV-2 基因组特征、药物和疫苗开发的最新进展;全面的生物信息学综述。
Microb Pathog. 2021 May;154:104809. doi: 10.1016/j.micpath.2021.104809. Epub 2021 Feb 27.
2
Comprehensive analyses of bioinformatics applications in the fight against COVID-19 pandemic.生物信息学在抗击新冠疫情中的应用综合分析。
Comput Biol Chem. 2021 Dec;95:107599. doi: 10.1016/j.compbiolchem.2021.107599. Epub 2021 Nov 2.
3
Bioinformatics analysis of epitope-based vaccine design against the novel SARS-CoV-2.基于表位的新型 SARS-CoV-2 疫苗设计的生物信息学分析。
Infect Dis Poverty. 2020 Jul 10;9(1):88. doi: 10.1186/s40249-020-00713-3.
4
SARS-CoV-2: An Update on Genomics, Risk Assessment, Potential Therapeutics and Vaccine Development.SARS-CoV-2:基因组学、风险评估、潜在治疗方法和疫苗开发的最新进展。
Int J Environ Res Public Health. 2021 Feb 8;18(4):1626. doi: 10.3390/ijerph18041626.
5
Semi-Supervised Pipeline for Autonomous Annotation of SARS-CoV-2 Genomes.用于 SARS-CoV-2 基因组自主注释的半监督流水线。
Viruses. 2021 Dec 3;13(12):2426. doi: 10.3390/v13122426.
6
A comprehensive genomic study, mutation screening, phylogenetic and statistical analysis of SARS-CoV-2 and its variant omicron among different countries.一项针对 SARS-CoV-2 及其不同国家变异株奥密克戎的全基因组研究、突变筛查、系统进化和统计学分析。
J Infect Public Health. 2022 Aug;15(8):878-891. doi: 10.1016/j.jiph.2022.07.002. Epub 2022 Jul 8.
7
Longitudinal analysis of SARS-CoV-2 spike and RNA-dependent RNA polymerase protein sequences reveals the emergence and geographic distribution of diverse mutations.对 SARS-CoV-2 刺突蛋白和 RNA 依赖性 RNA 聚合酶蛋白序列的纵向分析揭示了多种突变的出现和地理分布。
Infect Genet Evol. 2022 Jan;97:105153. doi: 10.1016/j.meegid.2021.105153. Epub 2021 Nov 18.
8
In-silico immunoinformatic analysis of SARS-CoV-2 virus for the development of putative vaccine construct.基于 SARS-CoV-2 病毒的计算免疫信息学分析,以开发可能的疫苗构建体。
Immunobiology. 2021 Sep;226(5):152134. doi: 10.1016/j.imbio.2021.152134. Epub 2021 Aug 28.
9
Role of genomics in combating COVID-19 pandemic.基因组学在抗击 COVID-19 大流行中的作用。
Gene. 2022 May 20;823:146387. doi: 10.1016/j.gene.2022.146387. Epub 2022 Mar 4.
10
Comparative Genomics Reveals Early Emergence and Biased Spatiotemporal Distribution of SARS-CoV-2.比较基因组学揭示了 SARS-CoV-2 的早期出现和偏时空分布。
Mol Biol Evol. 2021 May 19;38(6):2547-2565. doi: 10.1093/molbev/msab049.

引用本文的文献

1
Efficacy of Inactivated Bivalent SARS-CoV-2 Vaccines Targeting Ancestral Strain (ERAGEM), Delta, and Omicron Variants.针对原始毒株(ERAGEM)、德尔塔和奥密克戎变种的二价新冠病毒灭活疫苗的效力
Vaccines (Basel). 2025 Feb 10;13(2):169. doi: 10.3390/vaccines13020169.
2
Bioinformatics and molecular biology tools for diagnosis, prevention, treatment and prognosis of COVID-19.用于COVID-19诊断、预防、治疗和预后的生物信息学与分子生物学工具
Heliyon. 2024 Jul 11;10(14):e34393. doi: 10.1016/j.heliyon.2024.e34393. eCollection 2024 Jul 30.
3
State of the art in epitope mapping and opportunities in COVID-19.

本文引用的文献

1
Harnessing Recent Advances in Synthetic DNA and Electroporation Technologies for Rapid Vaccine Development Against COVID-19 and Other Emerging Infectious Diseases.利用合成DNA和电穿孔技术的最新进展快速开发针对COVID-19和其他新兴传染病的疫苗
Front Med Technol. 2020 Oct 21;2:571030. doi: 10.3389/fmedt.2020.571030. eCollection 2020.
2
On the origin and continuing evolution of SARS-CoV-2.关于严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的起源及持续进化
Natl Sci Rev. 2020 Jun;7(6):1012-1023. doi: 10.1093/nsr/nwaa036. Epub 2020 Mar 3.
3
Publisher Correction: ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques.
表位作图的现状与 COVID-19 中的机遇
Future Sci OA. 2023 Feb;16(3-06):FSO832. doi: 10.2144/fsoa-2022-0048. Epub 2023 Mar 6.
4
Bioinformatics analysis of the potential regulatory mechanisms of renal fibrosis and the screening and identification of factors related to human renal fibrosis.肾纤维化潜在调控机制的生物信息学分析及人类肾纤维化相关因子的筛选与鉴定
Transl Androl Urol. 2022 Jun;11(6):859-866. doi: 10.21037/tau-22-366.
出版商更正:ChAdOx1新型冠状病毒疫苗可预防恒河猴感染新型冠状病毒肺炎。
Nature. 2021 Feb;590(7844):E24. doi: 10.1038/s41586-020-03099-2.
4
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.BNT162b2 mRNA 新冠病毒疫苗的安全性和有效性。
N Engl J Med. 2020 Dec 31;383(27):2603-2615. doi: 10.1056/NEJMoa2034577. Epub 2020 Dec 10.
5
Neutralizing antibodies for the treatment of COVID-19.针对 COVID-19 的中和抗体治疗。
Nat Biomed Eng. 2020 Dec;4(12):1134-1139. doi: 10.1038/s41551-020-00660-2.
6
Efforts at COVID-19 Vaccine Development: Challenges and Successes.新冠疫苗研发的努力:挑战与成功
Vaccines (Basel). 2020 Dec 6;8(4):739. doi: 10.3390/vaccines8040739.
7
Evaluating the Effects of SARS-CoV-2 Spike Mutation D614G on Transmissibility and Pathogenicity.评估 SARS-CoV-2 刺突突变 D614G 对传染性和致病性的影响。
Cell. 2021 Jan 7;184(1):64-75.e11. doi: 10.1016/j.cell.2020.11.020. Epub 2020 Nov 19.
8
Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18-59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial.一项在 18-59 岁健康成年人中进行的新型冠状病毒灭活疫苗的安全性、耐受性和免疫原性的随机、双盲、安慰剂对照、1/2 期临床试验。
Lancet Infect Dis. 2021 Feb;21(2):181-192. doi: 10.1016/S1473-3099(20)30843-4. Epub 2020 Nov 17.
9
Unexpected detection of SARS-CoV-2 antibodies in the prepandemic period in Italy.在意大利大流行前时期意外检测到 SARS-CoV-2 抗体。
Tumori. 2021 Oct;107(5):446-451. doi: 10.1177/0300891620974755. Epub 2020 Nov 11.
10
Protection against SARS-CoV-2 by BCG vaccination is not supported by epidemiological analyses.BCG 疫苗接种不能预防 SARS-CoV-2,这一结论得到了流行病学分析的支持。
Sci Rep. 2020 Oct 27;10(1):18377. doi: 10.1038/s41598-020-75491-x.